UK Renal Registry 2013 Annual Audit Meeting

Slides:



Advertisements
Similar presentations
VA Dataset National Kidney Care Audit. The audit measures two distinct areas: 1. Patient Transport Aim: To make visible the variation of provision and.
Advertisements

Responding to the Patient’s Voice: the importance of Patient Reported Outcomes Dr. Kirstie Haywood Senior Research Fellow RCN Research Institute, School.
Right Care for Patients The National Shared Decision Making Programme.
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
Regional & National Context Rebecca Campbell Yorkshire & the Humber Renal Network Manager 15 th June 2011.
CD FORUM : R EGISTRY UPDATE, THE WHO WHAT, HOW, WHERE, WHEN AND WHAT NEXT. Damian Fogarty Chairman, United Kingdom Renal Registry Consultant Nephrologist.
Improving health outcomes across England by providing improvement and change expertise How to Measure Patient Activation Measuring Patient Activation In.
Improving quality through the Scottish Renal Registry UK Renal Registry 2015 Annual Audit Meeting Dr Jamie Traynor Technical Director, Scottish Renal Registry.
An update from The UK Renal Registry Dr Fergus Caskey Medical Director, UK Renal Registry Annual Informatics Meeting, September 2014.
Outcomes that matter to patients: Patient Reported Outcome Measures (PROMs) for people with renal replacement UK Renal Registry 2015 Annual Audit Meeting.
2014 Annual Report highlights and new directions for the UK Renal Registry UK Renal Registry 2015 Annual Audit Meeting Dr Fergus Caskey Medical Director,
Update on the UK Renal Data Collaboration (UKRDC) UK Renal Registry 2015 Annual Audit Meeting Dr Keith Simpson Medical Adviser, UK Renal Registry.
CKD Conservative care and preparation for dialysis UK Renal Registry 2013 Annual Audit Meeting Dr Anirudh Rao Registrar, UK Renal Registry.
September 5 th – 8 th 2013 Nottingham Conference Centre, United Kingdom
CAHPS Overview Clinician & Group Surveys: Practical Options for Implementation and Use AHRQ ANNUAL MEETING SEPTEMBER 18, 2011 Christine Crofton, PhD CAHPS.
Rowan Walker – Chairman Chair: Steve Chadban ANZDATA update (Stephen McDonald) Analgaesic nephropathy – the end of an epidemic? (Sean Chang)
IAPT LTC/MUS Pathfinder Evaluation Project: Interim Report IAPT LTC/MUS Pathfinder Event 21 st March 2013 Prof Simon de.
Development of Clinical Practice Guidelines for the NHS Dr Jacqueline Dutchak, Director National Collaborating Centre for Acute Care 16 January 2004.
1 Lecture 2: Types of measurement Purposes of measurement Types and sources of data Reliability and validity Levels of measurement Types of scale.
UKRR Annual Informatics Meeting, September 2013 Highlights from the 15 th Annual Report Rishi Pruthi Research Fellow UK Renal Registry.
DIRIGO HEALTH AGENCY’S MAINE QUALITY FORUM Statewide Patient Experience Survey August 2012 Patient Experience Matters.
Development of an interactive patient information web site - the importance of consumer involvement Peter Rutherford, Paul Forte, Tom Bowen, Rory Matthews.
2013 Annual Report highlights and new directions for the Registry
Feasibility and validity of four patient reported outcome measures in the Danish Hip Arthroplasty Registry Aksel Paulsen, M.D., Ph.D. Fellow Department.
Improving the utility of comorbidity records Retha Steenkamp UK Renal Registry.
The National Renal Dataset Charlie Tomson UKRR Annual Meeting 24 th June 2009.
Information, Quality and Values Donal O’Donoghue National Clinical Director for Kidney Care Working for better kidney care UKRR and NHS Kidney Care Information.
Data completeness reporting Alex Hodsman, David Bull, Paul Dawson UK Renal Registry.
Our Local Priorities for Sue Cavill Associate Director for Communications & Engagement.
Basic Economic Analysis David Epstein, Centre for Health Economics, York.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
Sustainable Health and Green Care Donal O’Donoghue National Clinical Director for Kidney Care Green Nephrology Summit London Wednesday 26 th September.
Renal Services Dr Donal O’Donoghue National Clinical Director for Kidney Care UKRR Annual Audit Meeting QEH Birmingham 30 September 2010 Working for Better.
Consistent Implementation of the NSF for Renal Services Beverley Matthews Director – NHS Kidney Care.
Highlights from the Annual Report UK Renal Registry 2013 Annual Audit Meeting Dr Catriona Shaw Registrar, UK Renal Registry.
CAHPS PATIENT EXPERIENCE SURVEYS AHRQ ANNUAL MEETING SEPTEMBER 2012 Christine Crofton, PhD CAHPS Project Officer.
NHS Benchmarking Data Susan Hamilton Consultant in Public Health South Gloucestershire Council.
Resolving Challenges in Data Collection, Aggregation, and Use of Standardized Measures Dolores Yanagihara, MPH Integrated Healthcare Association February.
Randomised controlled trials in primary care: case study Doctor Sue Wilson University of Birmingham United Kingdom.
RaDaR – a national web based data collection for rare kidney diseases Moin Saleem – University of Bristol Mark Taylor – Birmingham Children’s Hospital.
Highlights from the Registry year and Annual Report Professor Terry Feest Assistant Director UK Renal Registry UK Renal Registry 2011 Annual Audit Meeting.
UK Renal Registry Update 2010 and future plans. Chris Maggs Deputy Director.
NIPEC Annual Conference Professional Standards Enhancing Person-Centred Care Assisted Automated Peritoneal Dialysis(aAPD) Susie Mawhinney PD Nurse BCH.
The Hospital CAHPS Program Presented by Maureen Parrish.
Driving Quality and Equity through PREMs and PROMs Michelle Price, Consultant Therapist for Stroke and Neurological Conditions Powys Teaching Health Board.
Intelligent Targets for Depression Dr Adrian Jones, ACOS Dr Alys Cole King, Consultant Liaison Psychiatrist Dr Teresa Ching, Consultant Respiratory Physician.
Patient-Reported Outcomes Measurement Group Elizabeth Gibbons Senior Research Officer
PROMs Pilot for Long-Term Conditions in Primary Care Ray Fitzpatrick Department of Public Health.
LifeCIT Development and pilot evaluation of a web-supported programme of Constraint Induced Therapy following stroke (LifeCIT) Meagher C 1, Conlon A 2,
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
PROMs Martin Orton – NHS Information Centre. Overview PROMs Overview IC’s central role in implementation –Matching & linking to HES & NJR –Applying the.
Transforming Participation in CKD Rachel Gair Person Centred Care Facilitator.
A CUTE KIDNEY INJURY REQUIRING RRT IN RENAL UNITS Catriona Shaw Research Fellow UK Renal Registry UKRR Audit Day, October 2012.
Access to transplant in the UK The ATTOM study Dr Rommel Ravanan On behalf of ATTOM investigators.
Valuing Individuals - Transforming Participation
Walking the walk or just talking the talk: how do we make progress?
IT Solutions – Improving Timely Access to Health Care
NICOR A NICE Commissioned Pilot of Patient Reported Outcome Measures (PROMs) for Ablation of Cardiac Arrhythmias Withers KL 1, Patrick H 2, Cunningham.
Fig 7.1 Median URR achieved in each renal unit
Development of an electronic personal assessment questionnaire to capture the impact of living with a vascular condition: ePAQ-VAS Patrick Phillips, Elizabeth.
UK Renal Registry 16th Annual Report
UK Renal Registry 9th Annual Report 2006
Technology Working Group Meeting
UK Renal Registry 19th Annual Report
SHAREHD Roadmap & Toolkit
UK Renal Registry 16th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 16th Annual Report
Rajni Singhal, Janet E. Hux, Shabbir M H Alibhai, Matthew J. Oliver 
Presentation transcript:

UK Renal Registry 2013 Annual Audit Meeting What patients want? Patient reported outcomes and patient reported experience measures-An update Dr Fergus Caskey Medical Director, UK Renal Registry UK Renal Registry 2013 Annual Audit Meeting 1

Background Terminology PROM PREM Patient Reported Outcome Measure Quality of life Generic Disease specific PREM Patient Reported Experience Measure Questions relating to their healthcare experience

PROMs for kidney patients Lord Darzi “Next Stage” Review, 2008 PROMs before and after 4 surgical procedures Trial of PROMs in long term conditions (mainly primary care) First meeting with NHS Kidney Care, Sheffield Jan 2009 Oxford PROM group systematic review Stakeholders meeting, Jan 2010 Not sufficient evidence of benefit from major time and resource investment – needed research Unsuccessful application to NIHR HSR, April 2010 First meeting with DH, March 2012

What are we trying to achieve? Outcomes: To improve patients health status To improve patient satisfaction with their care To improve efficiency of resource use Processes: To increase and improve communication between patients and staff relating to their health and health care To increase patient engagement – behaviour, concordance, adherence To alter provider behaviour (and make it more patient centred)

Which instrument? Type: Health-related QOL Generic (e.g. SF-36, EQ-5D) Kidney disease specific (e.g. KDQOL, Dialysis symptom index) Patient experience/ patient satisfaction? Which instruments have been validated in the UK renal population? Which have the properties most suited for the purpose? Or use a bank of questions? What is the appropriate balance between information richness and respondent burden? Compare with other conditions (NHS question banks) in UK or kidney services in other countries (CAHPS)

Instrument properties Appropriateness - Is the content of the instrument appropriate to the questions which [it’s routine collection] intended to address? Reliability - Does the instrument produce results that are reproducible and internally consistent? Validity - Does the instrument measure what it claims to measure? Interpretability - How interpretable are the scores of an instrument? Responsiveness - Does the instrument detect changes that matter to patients (1) between respondents at a point in time (discriminative) or (2) in the same patients over time (evaluative)? Precision - How precise are the scores of the instrument? (For example, number of gradations of response) Acceptability - Is the instrument acceptable to patients? Feasibility - Is the instrument easy to administer and process? HTA 1998; 2: 14

Which patients? Options: Renal replacement therapy: Haemodialysis, in centre Haemodialysis, at home Peritoneal dialysis Kidney transplant +/- Conservative (non-dialytic therapy) +/- Chronic kidney disease stage 5, not yet on RRT +/- Acute kidney injury

The proposal – draft! 10 sites All dialysis patients – HD (in centre/ satellite/ home), PD PROM/ PREM collected quarterly for 12 months PROM: EQ-5D POS-s renal (symptoms) ? Recovery time question (for HD) PREM: Scottish Renal Patient Experience Questionnaire EVALUATE Link with DOPPS – BRS funded Staff & patients interviews & survey

EQ-5D-5L

POS-S renal

Patient Experience Questionnaire Healthcare Improvement Scotland

Collection and reporting Paper data collection Options: Local Collection and entry - immediately available Extracted by UKRR for reporting/ benchmarking National Posted to UKRR and scanned into database Weekly upload to local renal IT system

The proposal – outcomes Outcome measures Response rates Feasibility Cost Evaluation Mixed methods: interviews & survey

Scepticism ‘‘… written instruments are not helpful for history taking…the nuances of collecting a history cannot be embodied in a form… Forms are useless and time consuming.’’ ‘‘Is a PRO test really better than just asking: How is your walking [pain, depression,…] doing since I last saw you?’ Quality of Life Research 2009; 18:99-107

Where do we go from here? THE PILOT THE EVALUATION 10 sites All dialysis patients – HD (in centre/ satellite/ home), PD PROM/ PREM collected quarterly for 12 months PROM: EQ-5D POS-s renal (symptoms) ? Recovery time question (for HD) PREM: Scottish Renal Patient Experience Questionnaire THE EVALUATION Link with DOPPS – BRS funded Staff & patients interviews & survey TECHNICAL: “How does the instrument perform?” FUNDAMENTAL: “Is this useful?” “How could we make it more useful?”

Acknowledgements University of Bristol UKRR Oxford PROMs Group SRR Leila Rooshenas Amanda Owen-Smith Oxford PROMs Group Ray Fitzpatrick Elizabeth Gibbons NKF/ patients Nicholas Palmer DOPPS HughRayner Richard Fluck Jennie King Healthcare Improvement Scotland UKRR Ron Cullen Hilary Doxford David Bull Retha Steenkamp SRR Wendy Metcalfe Renal / epidemiology/ etc Paul Roderick Ken Farrington Richard Fluck Breeda McManus Fliss Murtagh DH/ NHS Kidney Care Donal O’Donoghue David Glover Giles Doy Bev Matthews